You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

abraxane

Showing 1 - 25 of 63
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immunotherapy;Envafolimab; Esophageal Cancer Trial (Envafolimab, Abraxane, Cisplatin)

Not yet recruiting
  • Immunotherapy;Envafolimab; Esophageal Cancer
  • (no location specified)
Apr 24, 2023

Advanced Adenocarcinoma, Metastatic Adenocarcinoma Trial in Philadelphia (Hydroxychloroquine (HCQ), Gemcitabine, Abraxane)

Completed
  • Advanced Adenocarcinoma
  • Metastatic Adenocarcinoma
  • Hydroxychloroquine (HCQ)
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Mar 29, 2022

Urothelial Carcinoma Trial in Ann Arbor (Pembrolizumab, Abraxane)

Active, not recruiting
  • Urothelial Carcinoma
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Dec 15, 2021

Solid Tumor, Adult, EphA2 Overexpression, KRAS G12V Trial in Beijing (KRAS-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

Recruiting
  • Solid Tumor, Adult
  • +4 more
  • KRAS-EphA-2-CAR-DC
  • +3 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinsese PLA Gereral Hospital
Nov 29, 2022

Patients With Stage IV or Recurrent Adenocarcinoma of the Lung Trial (Abraxane, Gemcitabine)

Completed
Has Results
  • Patients With Stage IV or Recurrent Adenocarcinoma of the Lung
  • (no location specified)
Sep 28, 2021

Solid Tumor, Adult, Lymphoma, EphA2 Overexpression Trial in Beijing (TP53-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

Recruiting
  • Solid Tumor, Adult
  • +6 more
  • TP53-EphA-2-CAR-DC
  • +3 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinsese PLA Gereral Hospital
Nov 29, 2022

Breast Cancer Trial in Houston, Sugar Land (T-DM1, Trastuzumab, Lapatinib)

Completed
Has Results
  • Breast Cancer
  • Houston, Texas
  • +2 more
Aug 27, 2021

Breast Tumors, Breast Cancer Trial in Houston, Sugar Land (Paclitaxel, Docetaxel, Abraxane)

Completed
Has Results
  • Breast Neoplasms
  • Breast Cancer
  • Houston, Texas
  • +2 more
Jan 19, 2023

NSCLC Trial in Tampa, Philadelphia (Durvalumab, Carboplatin, Abequolixron)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Tampa, Florida
  • +1 more
Jun 9, 2023

Endometrial Cancer Trial in New York (Carboplatin AUC, Abraxane)

Completed
Has Results
  • Endometrial Cancer
  • Carboplatin AUC
  • Abraxane
  • New York, New York
    NYU Perlmutter Cancer Center
Apr 20, 2021

Metastatic Breast Cancer Trial in Shanghai (Abraxane)

Completed
  • Metastatic Breast Cancer
  • Abraxane
  • Shanghai, China
    Fudan University Cancer Hospital
Feb 25, 2021

Pancreatic Adenocarcinoma Trial in Fairway (9-ING-41, Retifanlimab, Gemcitabine)

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • Fairway, Kansas
    Kansas University Cancer center
Nov 2, 2022

Metastatic Breast Cancer Trial in Morgantown (DOXIL, Abraxane)

Completed
Has Results
  • Metastatic Breast Cancer
  • Morgantown, West Virginia
    Clinical Trials Research Unit, West Virginia University
Dec 22, 2020

Breast Cancer, HER2-positive Breast Cancer Trial in Jinan (Pyrotinib Plus And, Trastuzumab, Abraxane)

Not yet recruiting
  • Breast Cancer
  • HER2-positive Breast Cancer
  • Pyrotinib Plus And
  • +2 more
  • Jinan, Shandong, China
    Zhiyong Yu
Nov 19, 2020

Breast Cancer Trial in Bridgeport, New Haven, Providence (Abraxane, Carboplatin, Avastin)

Completed
Has Results
  • Breast Cancer
  • Abraxane
  • +2 more
  • Bridgeport, Connecticut
  • +4 more
Apr 6, 2021

NSCLC (NSCLC) Trial in Omaha (biological, drug, radiation)

Withdrawn
  • Non-small Cell Lung Cancer (NSCLC)
  • AGS-003-LNG
  • +6 more
  • Omaha, Nebraska
    Cancer Research Network of Nebraska / Oncology Associates
Mar 3, 2022

Locally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy, Borderline Resectable Pancreatic Cancer Treated

Recruiting
  • Locally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy
  • Borderline Resectable Pancreatic Cancer Treated With Chemoradiotherapy
  • Radiotherapy
  • Abraxane
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Nov 15, 2021

Pancreatic Adenocarcinoma Resectable, Pancreatic Adenocarcinoma Locally Advanced, Pancreatic Adenocarcinoma Metastatic Trial in

Completed
  • Pancreatic Adenocarcinoma Resectable
  • +2 more
  • Edegem, Antwerpen, Belgium
  • +1 more
Sep 2, 2020

Squamous Cell Carcinoma of the Head and Neck Trial in Saint Louis (Abraxane, Cetuximab, Cisplatin)

Completed
Has Results
  • Squamous Cell Carcinoma of the Head and Neck
  • Abraxane
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 21, 2020

Ovarian Cancer Trial in Xiamen (Apatinib Mesylate, Abraxane, Cis Platinum)

Recruiting
  • Ovarian Cancer
  • Apatinib Mesylate
  • +3 more
  • Xiamen, Fujian, China
    Zhongshan Hospital Affiliated to Xiamen University
Oct 10, 2020

Invasive Ductal Breast Carcinoma Trial in Worldwide (Carboplatin, Abraxane, MPDL3280A)

Active, not recruiting
  • Invasive Ductal Breast Carcinoma
  • Innsbruck, Austria
  • +40 more
Jul 26, 2022

Pancreatic Adenocarcinoma Trial in Philadelphia (Gemcitabine, Abraxane, FOLFIRINOX)

Completed
Has Results
  • Pancreatic Adenocarcinoma
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Feb 24, 2021

Treatment of Pancreatic Cancer With Abraxane

Completed
  • Metastatic Pancreatic Cancer
  • Eisenstadt, Austria
  • +18 more
Oct 15, 2020

Advanced Solid Tumor, Metastatic Breast Cancer Trial in United States (Abraxane)

Active, not recruiting
  • Advanced Solid Tumor
  • Metastatic Breast Cancer
  • Abraxane
  • Gilbert, Arizona
  • +19 more
Jan 13, 2023

Colorectal Cancer, Cancer of Gastrointestinal Tract Trial in Houston (Abraxane)

Completed
Has Results
  • Colorectal Cancer
  • Cancer of Gastrointestinal Tract
  • Abraxane
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 9, 2020